Finio.com Revolutionizes F&I for Marine, Powersports, RV, and Truck
Serial entrepreneurs announce new FinTech venture IRVINE, Calif.–(BUSINESS WIRE)–Finio, Inc. reimagines the digital sales and…
Month: July 2023
Fivetran Expands Data Movement Platform to Multiple Geographies Helping More Customers Unlock Data to Power AI/ML Services and Data-Driven Decisions
Fivetran Supports 25+ Cloud Regions, Enabling Customers to Meet Stringent Data Governance and Data Residency…
WNS Announces Fiscal 2024 First Quarter Earnings, Revises Full Year Guidance
NEW YORK & MUMBAI, India–(BUSINESS WIRE)–$WNS #BusinessProcessManagement–WNS (Holdings) Limited (WNS) (NYSE: WNS), a leading provider…
FICO Wins Innovators 2023 Award from Global Finance for Blockchain in AI Model Governance
Blockchain for AI Model Governance tracks development, operationalization and monitoring of machine learning models to…
With Intelligence Announces That Motive Partners Has Acquired a Majority Stake
Investment to accelerate the development of With Intelligence’s data & analytics platform and penetration of…
Sosei Heptares – Investor and Press Conference on Today’s Announcement Regarding the Acquisition and License Transaction with Idorsia
Tokyo, Japan and Cambridge, UK, 20 July 2023 – Sosei Group Corporation (“the Company”; TSE:…
Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company
Transaction adds complementary late-stage clinical development capability with profitable and fast-growing commercial operations in Japan…
Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 20, 2023 Idorsia…
Verona Pharma to Report Second Quarter 2023 Financial Results and Provide Corporate Update
LONDON and RALEIGH, N.C., July 20, 2023 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Sandoz announces plans to build a Biosimilar Technical Development Center in Slovenia to support future growth of biosimilar pipeline
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development…
New clinical and real-world data for Roche’s Vabysmo at ASRS reveal improved outcomes for people with two leading causes of vision loss
Late-breaking post-hoc data indicate Vabysmo leads to less fibrosis, which may negatively impact vision, than…
argenx to Report Half Year 2023 Financial Results and Second Quarter Business Update on July 27, 2023
July 20, 2023 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
ATTIA Announces the Travel Changemakers Awards Judges Panel
SINGAPORE, July 20, 2023 – (ACN Newswire) – The Asia Travel Technology Industry Association (ATTIA)…
Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab as the First-line Treatment of Extensive-stage Small Cell Lung Cancer
SHANGHAI, China, July 19, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,”…
Coloured Ties Capital Inc. Announces Change of Auditor
Vancouver, British Columbia–(Newsfile Corp. – July 19, 2023) – Coloured Ties Capital Inc. (TSXV: TIE)…
Sarson Funds Employs Blockpass’ KYC for BCH, CSPR Stablecoins
HONG KONG, Jul 20, 2023 – (ACN Newswire) – This week sees the announcement that…
BayWa r.e.’s Unwavering Dedication to the Community of Lang Son Province with Improved Commune Cultural House
HO CHI MINH CITY, VIETNAM, Jul 20, 2023 – (ACN Newswire) – Global renewable energy…
HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 20, 2023 (GLOBE NEWSWIRE) —…
Eisai Presents Latest Analysis of Lecanemab’s Effect on Biomarker Changes and Subcutaneous Dosing at The Alzheimer’s Association International Conference (AAIC) 2023
Further Phase 3 analysis shows benefits of lecanemab on both amyloid-beta and tau, two underlying…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Masimo Corporation (MASI) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…